Vector Science & Therapeutics and Caresyntax Announce Real-World Evidence Partnership for VectorMist

Caresyntax will design and operate a multi-phase real-world evidence program for Vector, culminating in a prospective comparative registry across a network of partner surgical facilities. The program will compare postoperative outcomes (opioid utilization, length of stay, and...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.